Saturday, February 7, 2015

Greece lawmakers meet as default fears loom

Greece lawmakers meet as default fears loom



[ATHENS] Greece's hard-left government was set to meet on Saturday, after sparking fresh fears of a default by demanding temporary funding from its European creditors before renegotiating its foreign loans.
The meetings comes after Athens put itself back on a collision course with the European Union by announcing it wanted to talk "without pressure and blackmail", days before an extraordinary meeting of eurozone ministers in Brussels.
Greece's new government and EU leaders held intense discussions this week, in which Athens clashed with Germany over its promises to end austerity and cut Greece's huge mountain of debt.
With the European portion of Greece's 240-billion-euro (S$372 billion) international bailout due to expire at the end of the month, investors are increasingly concerned recession-hit Greece could default on its repayments.






Credit rating agency Standard & Poor's late Friday downgraded Greece to just one notch above the range indicating vulnerability to a default, warning against further delays to debt talks.
In the "worst-case scenario," it said, Greece could finally exit the eurozone.
Moody's, another ratings agency, said it was placing Greece on review for a downgrade because of "considerable uncertainty regarding the outcome of the ensuing negotiations".
Greece is entitled to another 7.2 billion euros in loans under the huge aid plan first agreed in 2010, money it desperately needs to keep afloat.
But the radical new government says swingeing cuts forced under the terms of the bailout have crippled the economy, and prefers instead to rip up the programme and start again.
Greece is expected to return to growth this year after six years of recession that has left it with sky high unemployment and its economy in tatters.
NO BRIDGING LOANS
If Greece will not accept the funds and cannot reach agreement on new terms, its European partners want it to extend the programme - something Athens's new leaders say they will not do.
Instead, they want 1.9 billion euros of profits made by the European Central Bank from holding Greek government bonds, and permission to issue additional short-term debt.
"The bridge programme... is an official expression of the will of all sides to negotiate without pressure and blackmail," a government source said, referring to the temporary funding deal.
"The final Greek proposals... will be tabled after the bridge agreement." Hours earlier the head of the eurozone group of finance ministers, the so-called Eurogroup, had already dismissed the notion of temporary funding demanded by Greece.
"We don't do bridging loans," Jeroen Dijsselbloem told reporters in The Hague, according to Bloomberg.
The Eurogroup is holding a special meeting on Wednesday, the day before EU leaders meet for their regular summit, to discuss the escalating stand-off over Greece.
Top economy Germany, which is opposed to any debt relief or an easing of the austerity measures demanded of the bailout loans, said it expected Athens to set out its plans at the meeting.
"Before then, we expect the Greek government will make a proposal on how things should move forward," German foreign ministry spokesman Martin Jaeger said.
A Greek government source earlier said the meeting was a "welcome" chance to discuss its plans.
Spokesman Gabriel Sakellaridis told Vima Radio that it was in no sense an ultimatum, adding: "The sooner a solution is found, the better for the government and for the EU."
More details on Greece's plans may emerge when the government unveils its legislative programme on Sunday evening.
Greek prime minister Alexis Tsipras and finance minister Yanis Varoufakis visited Paris, London, Rome, Frankfurt, Brussels and Berlin this week to try to win over EU allies.
Italy and France are fighting their own battles with Brussels over how to cut their huge debt piles, while the eurozone is struggling to shake off tepid growth and the threat of deflation.
Italian finance minister Pier Carlo Padoan stressed on Friday that the goal next week was not to set up a confrontation with Greece, but to "look for shared solutions".
"We need to find a solution that puts Greece back on a path to sustainable economic growth and is compatible with its financial commitments," he said, according to Italian news agencies.
Addressing the first meeting of his Syriza party lawmakers in parliament Thursday, Mr Tsipras insisted his government would keep its campaign promises to end austerity.
"We are a sovereign country, we have democracy, we have a contract with our people, we will honour this agreement," he said.
In a remarkable show of support for the government, thousands of people gathered outside parliament Thursday evening, standing silently in Syntagma Square.
AFP











US refineries strike to widen as walkouts planned at BP plants

US refineries strike to widen as walkouts planned at BP plants


[HOUSTON] A strike by US refinery workers is set to widen late Saturday night as walkouts have been scheduled at BP Plc refineries in Indiana and Ohio, said a BP spokesman.
Strikes by hourly workers represented by the United Steelworkers union (USW) are set to begin at BP's Whiting, Indiana, and Toledo, Ohio, refineries at 11.59 local time Saturday. The Ohio refinery is a joint venture with Husky Energy .
About 4,000 workers are currently on strike at nine plants in California, Kentucky and Texas, including seven refineries that account for 10 per cent of US refining capacity.
REUTERS





Swiss trade union calls for central bank to weaken franc

Swiss trade union calls for central bank to weaken franc


[ZURICH] Switzerland's largest union on Friday urged the Swiss National Bank (SNB) to weaken Switzerland's currency to support the export-reliant country's economy.
Switzerland's central bank abandoned a cap on the franc of 1.20 per euro on Jan 15, stoking fears of a recession and prompting some businesses to cut pay and jobs, since a stronger franc makes Swiss exports more expensive.
The Swiss Federation of Trade Unions (SGB) called for the central bank to introduce measures that would weaken the franc and help to protect Swiss salaries and jobs.
"The most effective instrument is an explicit currency cap or target price - supplemented if required through negative interest rates or limiting the trading of the franc if need be," the SGB said in a statement.



A spokesman for the central bank did not immediately respond to a request for comment.
The SNB has already introduced negative interest rates for some banks.
On Sunday, a Swiss newspaper reported the SNB is unofficially targeting an exchange rate of 1.05-1.10 francs per euro. The central bank declined to comment on the story at the time.
Berne-based SGB also called for the Swiss government to make it illegal for Swiss employers to pay staff in euros, which some businesses have begun offering as an option to employees who commute to work from the eurozone.
The euro has weakened more than 10 percent against the franc since the currency cap was ended.
REUTERS




A Trans-Pacific Partnership reality check

A Trans-Pacific Partnership reality check


[WASHINGTON] As the Obama administration and a Republican-majority Congress work toward eventual approval of the Trans-Pacific Partnership trade agreement between the United States and 11 Pacific Rim nations, opponents of the proposed pact are issuing increasingly shrill warnings.
The latest is that the deal will endanger not only US jobs but also US health care - and health care around the world.
According to the critics, US efforts to protect the pharmaceutical industry's intellectual-property rights and commercial interests could result in higher drug prices and lower access - not only along the Pacific Rim but also in the United States.
The TPP means "worse health and unnecessary deaths," Joseph Stiglitz, a Nobel laureate in economics, warns.



Well, don't believe the hype.
The United States already has free-trade agreements, including chapters on pharmaceuticals, with several of the TPP countries (Australia, Canada, New Zealand, Peru, Chile, Mexico and Singapore), so the additional integration under the new deal would not change the status quo dramatically.
It's true that, as critics say, President Obama's trade negotiators are shooting for the 12 years of data protection, and higher prices that come with it, that developers of cutting-edge biologic medicines enjoy under US law.
They're unlikely to get it, because the maximum term in the other TPP countries is eight years. A compromise is already under discussion that would finesse the issue while allowing the only truly poor TPP country, Vietnam, quicker access to cheaper "bio-similar" versions of the drugs.
The other accusation is that the United States is trying to use TPP as a battering ram to bring down the prevailing drug-price controls in countries with national health insurance, such as Australia.
It's true that the United States seeks due process and transparency for US drug makers that want inclusion in these countries' state-controlled systems, but this is a far cry from undermining those politically popular systems - which other TPP countries would never allow anyway. Still less plausible is that TPP rules in this regard could set a precedent to weaken the United States' own bulk-pricing schemes for drugs in Medicaid or the VA health-care system, as the opponents allege.
The United States, and the world, desperately needs medical innovation, but the difficult fact is that it costs money - billions of dollars sometimes - to develop effective new drugs. One way to incentivize that investment is to offer companies a temporary government-guaranteed monopoly on commercial exploitation of their discoveries. Obviously, there's a trade-off: Drug prices must be high enough to encourage risk-taking but not so high as to limit access or bankrupt insurance systems. The United States, which accounts for 4.5 per cent of the world's population but 39 per cent of global spending on pharmaceuticals, probably subsidizes health systems in Europe and elsewhere. The robust intellectual-property rights and relatively higher prices US drug firms enjoy in their domestic market enable them to sell medicine in price-controlled markets abroad. No doubt that system is imperfect, but the TPP is best understood as a realistic effort to make it work better.
WP




728 X 90

336 x 280

300 X 250

320 X 100

300 X600